Delivery Order SPE2DB22D3016-SPE2DB24FBGQ0
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,022.70, is for the delivery of GAMUNEX-C, a 40 gram/400 ml vial of pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 23, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GAMUNEX-C 40 gram/400 ml vials, a medical product used for various healthcare purposes. The contract has a firm fixed price and a ceiling value of $13,963.20, with a period of performance through April 28, 2025. This award is not set-aside and represents an open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,544.00, is for the delivery of GAMUNEX-C 40 gram/400 mL vials, a pharmaceutical product, with a performance period extending through May 7, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,636.00, is for the delivery of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $115,417.92 firm-fixed-price contract is for the supply of GAMUNEX-C 40 gram/400 mL vials, a specialized immunoglobulin medication. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, a specialty medication. The contract has an ultimate completion date of February 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract has a ceiling value of $25,972.68 and a completion date of December 7, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,327.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, with a performance period through May 9, 2025. The contract is not set aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,272.00, is for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a ceiling value of $13,963.20 and an ultimate completion date of June 6, 2025. The contract is not set-aside and was awarded on May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FBGQ0Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of GAMUNEX-C 40 gram/400 ml vials, a pharmaceutical product. The contract has a firm fixed price of $7,213.62 and a completion date of October 2, 2024. The award is not set aside for any particular business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities. This contract award is likely part of AmerisourceBergen's broader effort to provide essential pharmaceutical and medical supplies to support various government healthcare programs and military treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/11/24 |